Physician
Shary Gardens Pediatrics
Shary Gardens Pediatrics was paid $2.18M by Medicaid between Jan 2020 and Dec 2024, across 59 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 30% of everything it billed.
33Billing provider infoSHARY GARDENS PEDIATRICS
MISSION, TX 78572
MISSION, TX 78572
33aNPI1932445913assigned 12/20/2012
33bProvider typePediatrics Physician
28Total paid$2.18M
24GClaims94,950
24DCodes billed59
24AFirst – last monthJan 2020 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Texas
Rank by total paid#227 of 1,136
Median peer was paid$329K
This provider vs. median6.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 1,684 | $32K | |
| 2021 | 15,678 | $355K | |
| 2022 | 28,149 | $655K | |
| 2023 | 26,160 | $597K | |
| 2024incomplete | 23,279 | $544K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 30% | 18,867 | 14,322 | $644K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 13% | 5,864 | 5,105 | $283K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 13% | 7,484 | 6,555 | $283K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 7.9% | 13,313 | 11,316 | $173K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6.0% | 1,781 | 1,732 | $131K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 5.0% | 1,522 | 1,463 | $109K |
| S8301 | Infection control supplies, not otherwise specified | 4.7% | 6,278 | 5,244 | $103K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 4.5% | 7,424 | 3,377 | $97K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 4.0% | 1,139 | 1,109 | $87K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 3.6% | 6,989 | 3,053 | $78K |
| 99429 | 1.9% | 1,306 | 1,270 | $42K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.1% | 319 | 300 | $24K |
47 more codes
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.1% | 2,871 | $23K |
| 99000 | <1% | 1,450 | $14K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,193 | $13K |
| 92558 | <1% | 1,717 | $11K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 175 | $10K |
| 87807 | <1% | 855 | $9K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 208 | $8K |
| 90461 | <1% | 2,482 | $8K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 88 | $6K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 501 | $5K |
| 99381 | <1% | 64 | $5K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 137 | $4K |
| 92550 | <1% | 139 | $2K | |
| 99050 | <1% | 171 | $2K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 979 | $1K |
| 99383 | <1% | 14 | $1K | |
| 0071A | <1% | 29 | $1K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 25 | $821.38 |
| 87428 | <1% | 14 | $378.68 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 2,563 | $340.38 |
| 96160 | <1% | 179 | $321.75 | |
| 92552 | <1% | 55 | $208.25 | |
| 99051 | <1% | 120 | $194.22 | |
| 90686 | <1% | 375 | $19.35 | |
| 81003 | <1% | 14 | $19.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 13 | $2.23 |
| 90677 | <1% | 384 | $0.44 | |
| 90651 | <1% | 65 | $0.04 | |
| 90620 | <1% | 12 | $0.01 | |
| 90670 | 0% | 986 | $0.00 | |
| 99173 | 0% | 1,979 | $0.00 | |
| 90710 | 0% | 443 | $0.00 | |
| 90734 | 0% | 27 | $0.00 | |
| 90633 | 0% | 457 | $0.00 | |
| 90681 | 0% | 104 | $0.00 | |
| 90715 | 0% | 33 | $0.00 | |
| 90648 | 0% | 45 | $0.00 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 59 | $0.00 |
| 90680 | 0% | 629 | $0.00 | |
| 90723 | 0% | 232 | $0.00 | |
| 90696 | 0% | 71 | $0.00 | |
| 90698 | 0% | 60 | $0.00 | |
| 90697 | 0% | 443 | $0.00 | |
| 91307 | 0% | 40 | $0.00 | |
| 90656 | 0% | 97 | $0.00 | |
| 90647 | 0% | 38 | $0.00 | |
| 90619 | 0% | 29 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKHAN, SALMAN (OWNER)
| Provider | Location | Paid |
|---|---|---|
| Alrahman, LLC | Donna, TX | $2.88M |
| Sleep & Children Pulmonary Center INC | Pasadena, CA | $762K |
| Top Physicians INC | Los Angeles, CA | $176K |
| Salman Khan, a Medical Corporation | Los Angeles, CA | $66K |
| Express Lab Services INC | Skokie, IL | $29K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.